Mannatech Inc (MTEX) stock
MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/3045% below fair value
$6.30−2.68 (-29.84%)
Close on Nov 13, 2026Market cap $12.16MP/E –Yield –
Mannatech r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $800.00K, up 14.3% from the year before. Over ten years it grew -7.3% a year on average. The highest annual figure on record is $3.00M in fiscal 2011.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $800.00K | +14.3% |
| FY2024 | Dec 31, 2024 | $700.00K | -12.5% |
| FY2023 | Dec 31, 2023 | $800.00K | -20.0% |
| FY2022 | Dec 31, 2022 | $1.00M | -16.7% |
| FY2021 | Dec 31, 2021 | $1.20M | +50.0% |
| FY2020 | Dec 31, 2020 | $800.00K | -27.3% |
| FY2019 | Dec 31, 2019 | $1.10M | +10.0% |
| FY2018 | Dec 31, 2018 | $1.00M | -16.7% |
| FY2017 | Dec 31, 2017 | $1.20M | -14.3% |
| FY2016 | Dec 31, 2016 | $1.40M | -17.6% |
| FY2015 | Dec 31, 2015 | $1.70M | +6.3% |
| FY2014 | Dec 31, 2014 | $1.60M | 0.0% |
| FY2013 | Dec 31, 2013 | $1.60M | -15.8% |
| FY2012 | Dec 31, 2012 | $1.90M | -36.7% |
| FY2011 | Dec 31, 2011 | $3.00M | – |
See a number that looks wrong?